Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

  1. Ljungman, P.
  2. Tridello, G.
  3. Piñana, J.L.
  4. Ciceri, F.
  5. Sengeloev, H.
  6. Kulagin, A.
  7. Mielke, S.
  8. Yegin, Z.A.
  9. Collin, M.
  10. Einardottir, S.
  11. Lepretre, S.D.
  12. Maertens, J.
  13. Campos, A.
  14. Metafuni, E.
  15. Pichler, H.
  16. Folber, F.
  17. Solano, C.
  18. Nicholson, E.
  19. Yüksel, M.K.
  20. Carlson, K.
  21. Aguado, B.
  22. Besley, C.
  23. Byrne, J.
  24. Heras, I.
  25. Dignan, F.
  26. Kröger, N.
  27. Robin, C.
  28. Khan, A.
  29. Lenhoff, S.
  30. Grassi, A.
  31. Dobsinska, V.
  32. Miranda, N.
  33. Jimenez, M.-J.
  34. Yonal-Hindilerden, I.
  35. Wilson, K.
  36. Averbuch, D.
  37. Cesaro, S.
  38. Xhaard, A.
  39. Knelange, N.
  40. Styczynski, J.
  41. Mikulska, M.
  42. de la Camara, R.
  43. Erakutsi egile guztiak +
Aldizkaria:
Frontiers in Immunology

ISSN: 1664-3224

Argitalpen urtea: 2023

Alea: 14

Mota: Artikulua

DOI: 10.3389/FIMMU.2023.1125824 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus